St. Jude Medical Inc. announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe.

A large randomized controlled trial of ischemic postconditioning in patients who had experienced ST-segment elevation myocardial infarction (STEMI) failed to show the procedure significantly reduces death from any cause or hospitalization for heart failure.

April 19, 2016 — Researchers have confirmed that certain heart rhythm medications, when given by paramedics to patients with out-of-hospital cardiac arrest who had failed electrical shock treatment, improved likelihood of patients surviving transport to the hospital.

Delayed or deferred stent implantation in patients showed no clinical benefit in patients experiencing the deadliest form of heart attack, ST-segment elevation myocardial infarction (STEMI), according to research presented at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16).

St. Jude Medical Inc. announced the U.S. launch and first U.S. implants of the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) with MultiPoint Pacing Technology.

Considering RFID to track healthcare inventory?

Healthcare reform is changing the way you provide care. With a focus on cost efficiency and quality, tracking utilization and efficient inventory management are big opportunities in your Cardiovascular Suite to help you manage costs and support patient safety initiatives. See how using the right tool for the right supply is key to demonstrating ROI.

To view the video from Cardinal Health, please complete the registration form below.

The American College of Radiology (ACR), as a member of a coalition of leading medical societies, provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC).

FFR-CT, heartflow

Fractional flow reserve-computed tomography (FFR-CT) is still in the early stages of clinical implementation in the United States, but it is already changing clinical practice as a non-invasive alternative to diagnosing patients with chest pain. Approved by the U.S. Food and Drug Administration (FDA) in November 2014, the technology provides both anatomical and functional assessment of the coronary arteries, a task no other method has accomplished to date. 

DAIC spoke with three users of the HeartFlow FFR-CT technology, each in various stages of clinical practice:
Inventory management, analytics software, cardiology
GE Healthcare analytics

With all areas of healthcare now migrating to electronic medical record (EMR) platforms, the data they contain can be mined to use increasingly sophisticated analytics software. This includes pulling information to improve department or hospital management, quality assurance to boost outcomes and efficiency, and even the ability to identify patients who are ideal referrals for new clinical programs such as low-dose lung computed tomography (CT) cancer screenings, or candidates for peripheral artery disease revascularization. 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now